Depletion rate of blood eosinophils with mepolizumab, benralizumab and oral prednisolone in patients with severe asthma
Huvudupphovsmän: | , , , , , , , , |
---|---|
Materialtyp: | Conference item |
Språk: | English |
Publicerad: |
European Respiratory Society
2020
|
Sammanfattning: |
---|